JPH04341180A - Lactic acid bacterium containing highly unsaturated fatty acids and its production thereof - Google Patents
Lactic acid bacterium containing highly unsaturated fatty acids and its production thereofInfo
- Publication number
- JPH04341180A JPH04341180A JP3139470A JP13947091A JPH04341180A JP H04341180 A JPH04341180 A JP H04341180A JP 3139470 A JP3139470 A JP 3139470A JP 13947091 A JP13947091 A JP 13947091A JP H04341180 A JPH04341180 A JP H04341180A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- unsaturated fatty
- fatty acids
- lactic acid
- highly unsaturated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims abstract description 58
- 241000894006 Bacteria Species 0.000 title claims abstract description 31
- 239000004310 lactic acid Substances 0.000 title claims abstract description 29
- 235000014655 lactic acid Nutrition 0.000 title claims abstract description 29
- 235000021122 unsaturated fatty acids Nutrition 0.000 title claims abstract description 25
- 150000004670 unsaturated fatty acids Chemical class 0.000 title claims abstract description 25
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 238000012258 culturing Methods 0.000 claims abstract description 4
- 239000003925 fat Substances 0.000 claims description 9
- 239000003921 oil Substances 0.000 claims description 7
- 235000019198 oils Nutrition 0.000 claims description 7
- 235000021081 unsaturated fats Nutrition 0.000 claims description 2
- 235000019197 fats Nutrition 0.000 abstract description 6
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 abstract description 4
- 241000251468 Actinopterygii Species 0.000 abstract description 3
- 235000019688 fish Nutrition 0.000 abstract description 3
- 230000000144 pharmacologic effect Effects 0.000 abstract description 3
- 235000020778 linoleic acid Nutrition 0.000 abstract description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 abstract description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 abstract 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 abstract 1
- 229960004488 linolenic acid Drugs 0.000 abstract 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 description 24
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 20
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 18
- 235000014113 dietary fatty acids Nutrition 0.000 description 14
- 229930195729 fatty acid Natural products 0.000 description 14
- 239000000194 fatty acid Substances 0.000 description 14
- 150000004665 fatty acids Chemical class 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 10
- 229940090949 docosahexaenoic acid Drugs 0.000 description 10
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 10
- 229920000053 polysorbate 80 Polymers 0.000 description 10
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 9
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 9
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 9
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 8
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 7
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 235000014593 oils and fats Nutrition 0.000 description 5
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 235000021314 Palmitic acid Nutrition 0.000 description 4
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 4
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 3
- 235000021319 Palmitoleic acid Nutrition 0.000 description 3
- 235000021342 arachidonic acid Nutrition 0.000 description 3
- 229940114079 arachidonic acid Drugs 0.000 description 3
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 229960004232 linoleic acid Drugs 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 235000021360 Myristic acid Nutrition 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- 241000269851 Sarda sarda Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000021322 Vaccenic acid Nutrition 0.000 description 2
- UWHZIFQPPBDJPM-FPLPWBNLSA-M Vaccenic acid Natural products CCCCCC\C=C/CCCCCCCCCC([O-])=O UWHZIFQPPBDJPM-FPLPWBNLSA-M 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000002066 eicosanoids Chemical class 0.000 description 2
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- UWHZIFQPPBDJPM-BQYQJAHWSA-N trans-vaccenic acid Chemical compound CCCCCC\C=C\CCCCCCCCCC(O)=O UWHZIFQPPBDJPM-BQYQJAHWSA-N 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000555825 Clupeidae Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000194031 Enterococcus faecium Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- 241001504592 Trachurus trachurus Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 150000001982 diacylglycerols Chemical class 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 229940098330 gamma linoleic acid Drugs 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 150000002327 glycerophospholipids Chemical class 0.000 description 1
- 150000002339 glycosphingolipids Chemical class 0.000 description 1
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical compound Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 150000002759 monoacylglycerols Chemical class 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000006864 oxidative decomposition reaction Methods 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Seeds, Soups, And Other Foods (AREA)
- Cosmetics (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、高度不飽和脂肪酸類を
含有する乳酸菌及びその製造方法に関するものである。
該乳酸菌は食品、化粧品、農業、水産、化成品などの分
野において有用である。TECHNICAL FIELD The present invention relates to lactic acid bacteria containing highly unsaturated fatty acids and a method for producing the same. The lactic acid bacteria are useful in fields such as foods, cosmetics, agriculture, fisheries, and chemical products.
【0002】0002
【従来の技術】乳酸菌は本来有している薬理作用として
、■腸内で増殖し、有害菌の定着を阻止する物質を産生
したり、有害菌の定着場所を占拠する、■腸内では増殖
しないが、その菌体成分が有効物質として働き、直接生
体の免疫力を高めたり、コレステロールの吸収を阻止し
たり、あるいは腸内菌叢の改善に作用する、■腸内にお
いて腸内有害菌によって生成される菌体内毒素、エンテ
ロトキシン、アミン、アンモニアなどの生成を抑制する
、等により広く利用されているが、その菌体脂肪酸組成
の成分はパルミチン酸、パルミトオレイン酸、オレイン
酸が主であって、これらの脂肪酸の栄養的、薬理的価値
は乏しい。尚、高度不飽和脂肪酸は一切含有されていな
い。[Prior art] Lactic acid bacteria have inherent pharmacological actions such as: ■ Proliferate in the intestine, produce substances that prevent the colonization of harmful bacteria, and occupy the colonization site of harmful bacteria. ■ Proliferate in the intestine. However, the bacterial components act as active substances, directly increasing the body's immunity, blocking the absorption of cholesterol, or improving the intestinal flora. It is widely used to suppress the production of bacterial intratoxins, enterotoxins, amines, ammonia, etc., but its bacterial fatty acid composition is mainly palmitic acid, palmitooleic acid, and oleic acid. Therefore, these fatty acids have poor nutritional and pharmacological value. Furthermore, it does not contain any highly unsaturated fatty acids.
【0003】一方、リノール酸、アラキドン酸などの高
度不飽和脂肪酸はエイコサノイド前駆体として重要であ
る他、成長促進、皮膚湿潤作用などが知られている。
又、α−リノレイン酸、エイコサペンタエン酸、ドコサ
ヘキサエン酸などのω3系列の高度不飽和脂肪酸はω6
系列の高度不飽和脂肪酸にきっこうするエイコサノイド
前駆体として抗血栓、抗腫瘍、抗動脈硬化、抗炎症など
の作用の他、脂質低下作用や特にドコサヘキサエン酸に
おいては視力低下抑制、記憶改善などの作用が知られて
いる。これらの高度不飽和脂肪酸はいずれも必須脂肪酸
である。ω6系列の高度不飽和脂肪酸は陸棲の動物油脂
、植物の根等に含まれており、現在の食生活において十
分摂取可能であるが、ω3系列の高度不飽和脂肪酸、特
にエイコサペンタエン酸やドコサヘキサエン酸は海産生
物に特有の脂肪酸であり、肉食嗜好にある世代にとって
は不足しがちである。海産生物由来の食品が避けられが
ちである大きな要因はその芳香である。エイコサペンタ
エン酸やドコサヘキサエン酸も海産物の芳香の一成分で
あるが、それは酸化分解生成物のアルデヒドに由来する
。従って、これらの高度不飽和脂肪酸の酸化が困難な形
状で食品に添加できることが好ましい。On the other hand, highly unsaturated fatty acids such as linoleic acid and arachidonic acid are important as eicosanoid precursors, and are also known to have growth promoting and skin moisturizing effects. In addition, ω3 series highly unsaturated fatty acids such as α-linoleic acid, eicosapentaenoic acid, and docosahexaenoic acid are ω6
As an eicosanoid precursor associated with polyunsaturated fatty acids in the series, it has antithrombotic, antitumor, antiarteriosclerotic, and antiinflammatory effects, as well as lipid-lowering effects, and especially docosahexaenoic acid, which has effects such as suppressing vision loss and improving memory. Are known. All of these highly unsaturated fatty acids are essential fatty acids. Omega-6 series polyunsaturated fatty acids are found in terrestrial animal fats and oils, plant roots, etc., and can be consumed in sufficient amounts in the current diet, but omega-3 series polyunsaturated fatty acids, especially eicosapentaenoic acid and docosahexaenoic acid, is a fatty acid unique to marine organisms, and people of the generation who prefer meat eating tend to be deficient in it. A major reason why foods derived from marine organisms tend to be avoided is their aroma. Eicosapentaenoic acid and docosahexaenoic acid are also components of the aroma of seafood, but they are derived from aldehydes, which are oxidative decomposition products. Therefore, it is preferable that these highly unsaturated fatty acids can be added to foods in a form that is difficult to oxidize.
【0004】0004
【発明が解決しようとする課題】本発明の目的は、乳酸
菌の本来の有用性を保持すると共に、栄養上、薬理上価
値のある高度不飽和脂肪酸を摂取し易くするために高度
不飽和脂肪酸類を含有する乳酸菌を提供することにある
。[Problems to be Solved by the Invention] It is an object of the present invention to maintain the original usefulness of lactic acid bacteria and to improve the production of polyunsaturated fatty acids in order to facilitate the intake of nutritionally and pharmacologically valuable polyunsaturated fatty acids. An object of the present invention is to provide lactic acid bacteria containing the following.
【0005】[0005]
【課題を解決するための手段】本発明者らは、上記の目
的のために鋭意研究の結果、培地中に高度不飽和脂肪酸
類を含む油脂を添加して培養した乳酸菌の脂質について
、次のような知見を得た。即ち、■高度不飽和脂肪酸含
有乳酸菌菌体を蒸留水、界面活性剤、塩酸で洗浄しても
、該菌体中の高度不飽和脂肪酸が総脂肪酸の30%以上
と高いこと、■本発明で用いる乳酸菌の増殖速度は早く
、多量の菌体を短時間の中に得ることができる。[Means for Solving the Problems] As a result of intensive research for the above purpose, the present inventors have discovered the following regarding the lipids of lactic acid bacteria cultured by adding fats and oils containing highly unsaturated fatty acids to the medium. I gained this knowledge. That is, (1) Even if the cells of lactic acid bacteria containing highly unsaturated fatty acids are washed with distilled water, a surfactant, and hydrochloric acid, the polyunsaturated fatty acids in the cells are as high as 30% or more of the total fatty acids; (2) The present invention The lactic acid bacteria used have a fast growth rate, and a large amount of bacterial cells can be obtained in a short period of time.
【0006】本発明は、以上のような知見に基づいて完
成されたもので、乳酸菌を高度不飽和脂肪酸類又はそれ
らを含む油脂を添加した培地中にて培養することを特徴
とする高度不飽和脂肪酸類を含有する乳酸菌及びその製
造方法である。The present invention was completed based on the above findings, and is characterized by culturing lactic acid bacteria in a medium supplemented with highly unsaturated fatty acids or fats and oils containing them. Lactic acid bacteria containing fatty acids and a method for producing the same.
【0007】本発明で用いる高度不飽和脂肪酸類として
は、リノール酸、γ−リノレイン酸、アラキドン酸、α
−リノレイン酸、エイコサペンタエン酸、ドコサヘキサ
エン酸及びこれらの塩類、エステル類、トリアシルグリ
セロール、ジアシルグリセロール、モノアシルグリセロ
ール、グリセロリン脂質、グリセロ糖脂質、スフィンゴ
リン脂質、スフィンゴ糖脂質等が挙げられる。The highly unsaturated fatty acids used in the present invention include linoleic acid, γ-linoleic acid, arachidonic acid, and α-linoleic acid.
-Linoleic acid, eicosapentaenoic acid, docosahexaenoic acid and their salts, esters, triacylglycerol, diacylglycerol, monoacylglycerol, glycerophospholipid, glyceroglycolipid, sphingophospholipid, glycosphingolipid and the like.
【0008】これらの高度不飽和脂肪酸を含む油脂とし
ては、好ましくは総脂肪酸中の高度不飽和脂肪酸の占め
る割合が10%以上のものが良く、このようなものの例
を上げるとイワシ、サバ、アジなどの青背魚より抽出し
た油脂、マグロやカツオなどの大型海産魚の眼窩脂肪由
来の油脂、微生物由来の油脂、イカ肝臓より抽出した海
産物由来の油脂などが好ましい例としてあげられる。[0008] The oils and fats containing these highly unsaturated fatty acids are preferably those in which the proportion of highly unsaturated fatty acids in the total fatty acids is 10% or more, and examples of such oils include sardines, mackerel, and horse mackerel. Preferred examples include oils and fats extracted from blue-backed fish such as tuna and bonito, oils and fats derived from the orbital fat of large marine fish such as tuna and bonito, oils and fats derived from microorganisms, and oils and fats derived from marine products extracted from squid liver.
【0009】本発明で利用できる乳酸菌は特に属、種あ
るいは株などを限定されるものではないが、例えばエン
テロコッカス属、ラクトバチルス属、ビヒドバクテリウ
ム属が挙げられる。これらの乳酸菌については公的微生
物寄託機関などにて容易に入手できる。[0009] The lactic acid bacteria that can be used in the present invention are not particularly limited in genus, species, or strain, but include, for example, Enterococcus, Lactobacillus, and Bihydrobacterium. These lactic acid bacteria can be easily obtained from public microorganism depositories.
【0010】本発明の実施に当たっては、乳酸菌を常法
により例えば培地で培養し、これを遠心分離法で集め、
洗浄、乾燥して乳酸菌粉末を得る。この際の培地として
は例えば次の第1表に示す組成の培地を調製することが
できる。[0010] In carrying out the present invention, lactic acid bacteria are cultured using a conventional method, for example, in a medium, and collected by centrifugation.
Wash and dry to obtain lactic acid bacteria powder. As the culture medium at this time, for example, a culture medium having the composition shown in Table 1 below can be prepared.
【0011】
第1表 ─────────────
─────────────────
BHI(DIFCO)
3.7 %
仔牛脳浸出物
1.6 %
牛心臓浸出物
2.0 %
ペプトン
0.08
% バクトデキス
トロース 0.02 %
塩化ナトリウム
0.04 %
リン酸ナトリウ
ム 0.02 %
─────────────────────
─────────
pH 7.4[0011]
Table 1 ──────────────
──────────────────
BHI (DIFCO)
3.7%
calf brain exudate
1.6%
beef heart infusion
2.0%
peptone
0.08
% Bactodextrose 0.02%
sodium chloride
0.04%
Sodium phosphate 0.02%
──────────────────────
─────────
pH 7.4
【0012】添加する油脂は、培
地に対し0.001%〜10%、好ましくは0.002
%〜0.1%を添加することが乳酸菌の増殖及び高度不
飽和脂肪酸の取り込み率からみても望ましい。又乳酸菌
の培地に乳化剤を添加しても良い。[0012] The amount of oil and fat to be added is 0.001% to 10%, preferably 0.002% to the medium.
% to 0.1% is desirable from the viewpoint of the growth of lactic acid bacteria and the uptake rate of polyunsaturated fatty acids. An emulsifier may also be added to the lactic acid bacteria culture medium.
【0013】このような培地で培養された菌体を凍結乾
燥後、常法により塩酸メタノールにてメチルエステル化
すると、菌体中でエステル結合しているあらゆる脂肪酸
誘導体の脂肪酸組成をGLCで分析できる。又、湿菌体
或は乾燥菌体を有機溶剤などを用いて抽出し、シリカゲ
ルTLCにて脂質を分画した後各々の脂質の構成脂肪酸
を同様にして分析できる。上述の方法により、本発明の
菌体の構成脂肪酸は、ドコサヘキサエン酸、エイコサペ
ンタエン酸、アラキドン酸、リノレイン酸、リノール酸
、オレイン酸、パルミトオレイン酸、パルミチン酸、ミ
リスチン酸などであることがわかった。[0013] When the bacterial cells cultured in such a medium are freeze-dried and then methyl esterified with hydrochloric acid and methanol by a conventional method, the fatty acid composition of all fatty acid derivatives ester-bonded in the bacterial cells can be analyzed by GLC. . Alternatively, the fatty acids constituting each lipid can be analyzed in the same manner after extracting wet or dry bacterial cells using an organic solvent and fractionating the lipids using silica gel TLC. By the above method, it was found that the fatty acids constituting the bacterial cells of the present invention are docosahexaenoic acid, eicosapentaenoic acid, arachidonic acid, linoleic acid, linoleic acid, oleic acid, palmitoleic acid, palmitic acid, myristic acid, etc. Ta.
【0014】[0014]
実施例 1
エンテロコッカス・フェシウム(Enterococc
us faecium)IFO−3128をBHI3.
7%、マグロ眼窩脂肪から精製した遊離脂肪酸[ドコサ
ヘキサエン酸(95%)、エイコサペンタエン酸(4%
)]0.05%を含有した培地1L中で嫌気培養し、細
胞を遠心分離して集め、蒸留水で3回洗浄した菌体、更
に0.1%ポリオキシエチレンソルビタンモノオレエ−
ト[Tween 80(登録商標)]水溶液で3回洗浄
した菌体、更に6N塩酸で3回洗浄した菌体を乾燥して
乳酸菌粉末を得た。Example 1 Enterococcus faecium
us faecium) IFO-3128 to BHI3.
7%, free fatty acids purified from tuna orbital fat [docosahexaenoic acid (95%), eicosapentaenoic acid (4%)]
)] Cells were cultured anaerobically in 1 L of a medium containing 0.05%, centrifuged and collected, and washed three times with distilled water, followed by 0.1% polyoxyethylene sorbitan monooleate.
The bacterial cells washed three times with Tween 80 (registered trademark) aqueous solution and three times with 6N hydrochloric acid were dried to obtain lactic acid bacteria powder.
【0015】各洗浄条件下での乳酸菌の乾燥粉末0.2
gを8%塩酸メタノールに懸濁し、80℃、1時間反応
後生成した脂肪酸メチルエステルをGLCで分析し、高
度不飽和脂肪酸の含有量を定量した。[0015] Dry powder of lactic acid bacteria under each washing condition: 0.2
g was suspended in 8% hydrochloric acid methanol and reacted at 80° C. for 1 hour, and the resulting fatty acid methyl ester was analyzed by GLC to determine the content of highly unsaturated fatty acids.
【0016】蒸留水で3回洗浄しただけの菌体では、ド
コサヘキサエン酸及びエイコサペンタエン酸の菌体総脂
肪酸に対する割合(乾燥菌体1g当りの含有量)は、各
々87%(220mg)と3%(8mg)であった。[0016] In the bacterial cells that have been washed only three times with distilled water, the proportions of docosahexaenoic acid and eicosapentaenoic acid to the total fatty acids of the bacterial cells (content per 1 g of dry bacterial cells) are 87% (220 mg) and 3%, respectively. (8 mg).
【0017】0.1%ポリオキシエチレンソルビタンモ
ノオレエ−ト[Tween 80(登録商標)]水溶液
で洗浄した菌体では同様に32%(14mg)と3%(
1.5mg)であった。Similarly, bacterial cells washed with a 0.1% polyoxyethylene sorbitan monooleate [Tween 80 (registered trademark)] aqueous solution had a concentration of 32% (14 mg) and 3% (
1.5 mg).
【0018】6N塩酸の洗浄を行った菌体は、36%(
19mg)と4%(1.9mg)であった。[0018] The bacterial cells washed with 6N hydrochloric acid were 36% (
19 mg) and 4% (1.9 mg).
【0019】他の脂肪酸組成は蒸留水で洗浄しただけの
菌体の場合、ミリスチン酸0.1%、パルミチン酸1.
8%、パルミトオレイン酸0.6%、バクセン酸4%で
あった。又、0.1%ポリオキシエチレンソルビタンモ
ノオレエ−ト[Tween 80(登録商標)]水溶液
で洗浄した菌体では同様に1.2%、12.8%、5.
2%、29.4%であった。更に、6N塩酸の洗浄を行
った菌体は、0.7%、11.6%、4.4%、29.
3%であった。Other fatty acid compositions are 0.1% myristic acid and 1% palmitic acid in the case of bacterial cells that have only been washed with distilled water.
8%, palmitoleic acid 0.6%, and vaccenic acid 4%. Similarly, bacterial cells washed with a 0.1% polyoxyethylene sorbitan monooleate [Tween 80 (registered trademark)] aqueous solution had a concentration of 1.2%, 12.8%, and 5%.
2% and 29.4%. Furthermore, the bacterial cells washed with 6N hydrochloric acid were 0.7%, 11.6%, 4.4%, and 29%.
It was 3%.
【0020】実施例 2
エンテロコッカス・フェカリス(Enterococc
us faecalis)IFO−3181をBHI3
.7%、マグロ眼窩脂肪から精製した遊離脂肪酸[ドコ
サヘキサエン酸(95%)、エイコサペンタエン酸(4
%)]トグリセロールから化学的に合成したモノドコサ
ヘキサノイルグリセロール0.01%を含有した培地1
L中で好気培養し、細胞を遠心分離して集め、蒸留水で
3回洗浄した菌体、更に0.1%ポリオキシエチレンソ
ルビタンモノオレエ−ト[Tween 80(登録商標
)]水溶液で3回洗浄した菌体、更に6N塩酸で3回洗
浄した菌体を5mLの蒸留水に懸濁した後、4倍容のク
ロロホルム/メタノール(2:1)混合液で3回抽出し
た。Example 2 Enterococcus faecalis
US faecalis) IFO-3181 to BHI3
.. 7%, free fatty acids purified from tuna orbital fat [docosahexaenoic acid (95%), eicosapentaenoic acid (4
%)] Medium 1 containing 0.01% monodocosahexanoylglycerol chemically synthesized from toglycerol
The cells were cultured aerobically in L, collected by centrifugation, and washed three times with distilled water. The cells washed three times and the cells washed three times with 6N hydrochloric acid were suspended in 5 mL of distilled water, and then extracted three times with 4 volumes of a chloroform/methanol (2:1) mixture.
【0021】各洗浄条件の湿菌体から抽出した総脂肪酸
をシリカゲルTLC(展開液:クロロホルム/アセトン
/メタノール=91:8:1)で極性脂質を分画し、常
法に従って、8%塩酸メタノールを用い、80℃、1時
間反応後生成した脂肪酸メチルエステルをGLCで分析
し、高度不飽和脂肪酸の含有量を定量した。蒸留水で洗
浄しただけの菌体極性脂質の構成脂肪酸に占めるドコサ
ヘキサエン酸とエイコサペンタエン酸の割合(乾燥菌体
1g当りの含有量)は、各々13%(26mg)と4%
(8mg)であった。Polar lipids were fractionated from the total fatty acids extracted from wet bacterial cells under each washing condition using silica gel TLC (developing solution: chloroform/acetone/methanol = 91:8:1), and 8% hydrochloric acid/methanol was added according to a conventional method. After reaction at 80° C. for 1 hour, the fatty acid methyl ester produced was analyzed by GLC to determine the content of highly unsaturated fatty acids. The proportions of docosahexaenoic acid and eicosapentaenoic acid (content per 1 g of dry bacterial cell) in the fatty acids constituting the polar lipids of the bacterial cell just washed with distilled water are 13% (26 mg) and 4%, respectively.
(8 mg).
【0022】0.1%ポリオキシエチレンソルビタンモ
ノオレエ−ト[Tween 80(登録商標)]水溶液
で洗浄した菌体では同様に12%(3.6mg)と4%
(1.2mg)であった。Similarly, bacterial cells washed with 0.1% polyoxyethylene sorbitan monooleate [Tween 80 (registered trademark)] aqueous solution had a concentration of 12% (3.6 mg) and 4%.
(1.2 mg).
【0023】6N塩酸の洗浄を行った菌体は、9%(2
.7mg)と3%(0.9mg)であった。[0023] After washing with 6N hydrochloric acid, 9% (2
.. 7 mg) and 3% (0.9 mg).
【0024】他の脂肪酸組成は蒸留水で洗浄しただけの
菌体の場合、ミリスチン酸1.3%、パルミチン酸11
.3%、パルミトオレイン酸6.4%、バクセン酸52
%であった。[0024] Other fatty acid compositions are myristic acid 1.3% and palmitic acid 11% in the case of bacterial cells that have only been washed with distilled water.
.. 3%, palmitoleic acid 6.4%, vaccenic acid 52
%Met.
【0025】0.1%ポリオキシエチレンソルビタンモ
ノオレエ−ト[Tween 80(登録商標)]水溶液
で洗浄した菌体では同様に1.1%、11.2%、6.
1%、54.6%であった。更に、6N塩酸の洗浄を行
った菌体は、1.4%、11.7%、6.7%、56.
3%であった。Similarly, bacterial cells washed with a 0.1% polyoxyethylene sorbitan monooleate [Tween 80 (registered trademark)] aqueous solution had a concentration of 1.1%, 11.2%, and 6.
1% and 54.6%. Furthermore, the bacterial cells washed with 6N hydrochloric acid were 1.4%, 11.7%, 6.7%, and 56%.
It was 3%.
【0026】[0026]
【発明の効果】高度不飽和脂肪酸類を含む油脂を添加し
た培地中で乳酸菌を培養することによって、高度不飽和
脂肪酸類を含有した乳酸菌を効率よく短時間で製造する
ことが可能となった。[Effects of the Invention] By culturing lactic acid bacteria in a medium supplemented with fats and oils containing highly unsaturated fatty acids, it has become possible to efficiently produce lactic acid bacteria containing highly unsaturated fatty acids in a short time.
Claims (2)
[Claim 1] Lactic acid bacteria containing highly unsaturated fatty acids
らを含む油脂を添加した培地にて培養することを特徴と
する該高度不飽和脂肪酸類を含有する乳酸菌の製造方法
。2. A method for producing lactic acid bacteria containing highly unsaturated fatty acids, which comprises culturing the lactic acid bacteria in a medium supplemented with highly unsaturated fatty acids or fats and oils containing them.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3139470A JPH04341180A (en) | 1991-05-16 | 1991-05-16 | Lactic acid bacterium containing highly unsaturated fatty acids and its production thereof |
JP4147946A JPH05304967A (en) | 1991-05-16 | 1992-05-15 | Microorganism, containing highly unsaturated fatty acids and capable of producing lactic acid and its production |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3139470A JPH04341180A (en) | 1991-05-16 | 1991-05-16 | Lactic acid bacterium containing highly unsaturated fatty acids and its production thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04341180A true JPH04341180A (en) | 1992-11-27 |
Family
ID=15245994
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3139470A Pending JPH04341180A (en) | 1991-05-16 | 1991-05-16 | Lactic acid bacterium containing highly unsaturated fatty acids and its production thereof |
JP4147946A Pending JPH05304967A (en) | 1991-05-16 | 1992-05-15 | Microorganism, containing highly unsaturated fatty acids and capable of producing lactic acid and its production |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4147946A Pending JPH05304967A (en) | 1991-05-16 | 1992-05-15 | Microorganism, containing highly unsaturated fatty acids and capable of producing lactic acid and its production |
Country Status (1)
Country | Link |
---|---|
JP (2) | JPH04341180A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008167746A (en) * | 2006-12-11 | 2008-07-24 | Ajinomoto Co Inc | Method for producing l-amino acid |
JP2015126741A (en) * | 2015-03-02 | 2015-07-09 | 株式会社明治 | Method for producing fermented milk |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10139674A (en) * | 1996-11-11 | 1998-05-26 | Yakult Honsha Co Ltd | Production promoter of interleukin 12 |
JP4124478B2 (en) * | 2005-08-22 | 2008-07-23 | 学校法人明治大学 | Animal feed additives |
JP5458536B2 (en) * | 2008-09-17 | 2014-04-02 | 不二製油株式会社 | Method for producing lactic acid and additive for lactic acid fermentation |
-
1991
- 1991-05-16 JP JP3139470A patent/JPH04341180A/en active Pending
-
1992
- 1992-05-15 JP JP4147946A patent/JPH05304967A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008167746A (en) * | 2006-12-11 | 2008-07-24 | Ajinomoto Co Inc | Method for producing l-amino acid |
JP2015126741A (en) * | 2015-03-02 | 2015-07-09 | 株式会社明治 | Method for producing fermented milk |
Also Published As
Publication number | Publication date |
---|---|
JPH05304967A (en) | 1993-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7134938B2 (en) | Eicosapentaenoic Acid Producing Microorganisms, Fatty Acid Compositions, and Methods of Making and Using Them | |
KR101451415B1 (en) | Process for producing microbial fat or oil having lowered unsaponifiable matter content and said fat or oil | |
JP3985035B2 (en) | (N-6) Docosapentaenoic Acid-Containing Oil and Fat, Method for Producing the Oil and Use, and Use | |
EP0823475B1 (en) | Novel microorganisms capable of producing highly unsaturated fatty acids and process for producing highly unsaturated fatty acids by using the microorganisms | |
AU661674B2 (en) | Arachidonic acid and methods for the production and use thereof | |
JP4518674B2 (en) | Use of docosapentaenoic acid-containing substances | |
US7470527B2 (en) | Preparation of microbial oil | |
CA2675691C (en) | Methods for producing polyunsaturated fatty acid and lipid containing polyunsaturated fatty acid | |
JP2008136493A (en) | Method for production of arachidonic acid | |
JPH078215A (en) | Marine microalgal food raw material containing docosahexaenoic acid and its production | |
IL128166A (en) | Process for preparing docosahexaenoic acid and docosapentaenoic acid | |
JPH01215245A (en) | Animal feed containing highly unsaturated fatty acid added thereto | |
JPH04341180A (en) | Lactic acid bacterium containing highly unsaturated fatty acids and its production thereof | |
KR20060079789A (en) | Use of a single-cell protein material | |
JPS6087798A (en) | Production of eicosapentaenoic acid by algae | |
JP3044577B2 (en) | Production of photosynthetic bacteria containing polyunsaturated fatty acids | |
JP7262536B2 (en) | Lipid composition, use thereof and method for producing the same | |
JP2001245687A (en) | Lipid containing n-4 and/or n-7 highly unsaturated fatty acid and method for producing the lipid | |
JP3502903B2 (en) | Method for producing polyunsaturated fatty acid and polyunsaturated phospholipid | |
JPH08163990A (en) | Oil-and-fat-containing alga and production of oil-and-fat derived therefrom | |
JPH0723774A (en) | Lactic bacterium containing docosahexaenoic acid and its production | |
JP2002335951A (en) | Method for producing lipid-containing yeast | |
JPH0484892A (en) | Production of eicosapentaenoic acid | |
JPH11343236A (en) | Medicinal composition containing polybasic unsaturated fatty acid and health food |